Literature DB >> 19479145

Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine.

Annalisa Patrizi, Beatrice Raone, Francesco Savoia, Francesco Bacci, Alessandro Pileri, Carlotta Gurioli, Iria Neri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479145     DOI: 10.2340/00015555-0639

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  7 in total

Review 1.  [Tattooing agents and adverse reactions].

Authors:  G Wagner; V Meyer; M M Sachse
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

2.  Inflammatory Reactions to Red Tattoo Inks: Three cases highlighting an emerging problem.

Authors:  Ricardo Ruiz-Villaverde; Pablo Fernandez-Crehuet; Paula Aguayo-Carreras; Jose L Hernandez-Centeno; Carlos Cuenca-Barrales
Journal:  Sultan Qaboos Univ Med J       Date:  2018-09-09

3.  [31/f with livid erythematous papules and nodules : Preparation for the specialist examination: part 6].

Authors:  Luisa Hellmich
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

4.  Pseudolymphoma tattoo-induced.

Authors:  Giorgio Pasolini; Patrizia Ghidini; Mariachiara Arisi; Alessandra Pedretti; Marco Ungari; Piergiacomo Calzavara Pinton
Journal:  Dermatol Reports       Date:  2011-11-29

5.  Pseudolymphomatous Reaction to Red Tattoo Pigment.

Authors:  Ieva Saulite; Agnes Pekar-Lukacs; Katrin Kerl; Antonio Cozzio; Wolfram Hoetzenecker; Emmanuella Guenova
Journal:  Case Rep Dermatol       Date:  2018-06-14

6.  Treatment of a refractory allergic reaction to a red tattoo on the lips with methotrexate and Q-switched Nd-Yag laser.

Authors:  Sebastiaan A S van der Bent; Martijn B A van Doorn
Journal:  JAAD Case Rep       Date:  2022-01-19

7.  Ablative laser surgery for allergic tattoo reactions: a retrospective study.

Authors:  S A S van der Bent; Sanne Huisman; T Rustemeyer; A Wolkerstorfer
Journal:  Lasers Med Sci       Date:  2020-10-26       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.